These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 31013501

  • 1. Upper Limb Motor Function Affects the Outcome after Treatment with Botulinum Toxin A.
    Fujimura K, Kagaya H, Onaka H, Nagasawa N, Ishihara A, Okochi Y, Yamada M, Tanikawa H, Kanada Y, Saitoh E.
    Eur Neurol; 2019; 81(1-2):30-36. PubMed ID: 31013501
    [Abstract] [Full Text] [Related]

  • 2. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 3. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial.
    Hokazono A, Etoh S, Jonoshita Y, Kawahira K, Shimodozono M.
    J Hand Ther; 2022 Mar 31; 35(4):507-515. PubMed ID: 33820711
    [Abstract] [Full Text] [Related]

  • 5. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial.
    Wu YT, Yu HK, Chen LR, Chang CN, Chen YM, Hu GC.
    Arch Phys Med Rehabil; 2018 Nov 31; 99(11):2143-2150. PubMed ID: 30392753
    [Abstract] [Full Text] [Related]

  • 6. Prognosis prediction of the effect of botulinum toxin therapy and intensive rehabilitation on the upper arm function in post-stroke patients using hierarchical cluster analysis.
    Hara T, Niimi M, Yamada N, Shimamoto Y, Masuda G, Hara H, Abo M.
    Disabil Rehabil; 2022 Nov 31; 44(22):6815-6823. PubMed ID: 34547217
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.
    Neurorehabil Neural Repair; 2012 Sep 31; 26(7):812-21. PubMed ID: 22371239
    [Abstract] [Full Text] [Related]

  • 8. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A, Micello MF, Panza F, Fortunato F, Picelli A, Smania N, Logroscino G, Fiore P, Ranieri M.
    Clin Rehabil; 2015 Jan 31; 29(1):50-8. PubMed ID: 24917588
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of injection of botulinum toxin type A combined with home-based functional training for post-stroke patients with spastic upper limb hemiparesis.
    Takekawa T, Abo M, Ebihara K, Taguchi K, Sase Y, Kakuda W.
    Acta Neurol Belg; 2013 Dec 31; 113(4):469-75. PubMed ID: 23716062
    [Abstract] [Full Text] [Related]

  • 10. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P, Denis A, Gasq D, Chaleat-Valayer E, Yelnik A, Colin C, Botuloscope Group, Pérennou D.
    Ann Phys Rehabil Med; 2019 Jul 31; 62(4):207-213. PubMed ID: 31229700
    [Abstract] [Full Text] [Related]

  • 11. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG, Paik NJ, Lee SU, Oh BM, Chun MH, Kwon BS, Bang MS.
    PLoS One; 2015 Jul 31; 10(6):e0128633. PubMed ID: 26030192
    [Abstract] [Full Text] [Related]

  • 12. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV, Da Re C, Messineo I, Bonaiuti D.
    Eur J Phys Rehabil Med; 2015 Aug 31; 51(4):381-7. PubMed ID: 25358636
    [Abstract] [Full Text] [Related]

  • 13. Combined therapeutic application of botulinum toxin type A, low-frequency rTMS, and intensive occupational therapy for post-stroke spastic upper limb hemiparesis.
    Kakuda W, Abo M, Momosaki R, Yokoi A, Fukuda A, Ito H, Tominaga A, Umemori T, Kameda Y.
    Eur J Phys Rehabil Med; 2012 Mar 31; 48(1):47-55. PubMed ID: 22071503
    [Abstract] [Full Text] [Related]

  • 14. Botulinum Toxin and Dynamic Splint Restore Grasping Function after Stroke: A Case Report.
    Moskiewicz D, Mraz M, Chamela-Bilińska D.
    Int J Environ Res Public Health; 2023 Mar 10; 20(6):. PubMed ID: 36981781
    [Abstract] [Full Text] [Related]

  • 15. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019 Mar 10; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial.
    Lee J, Chun MH, Ko YJ, Lee SU, Kim DY, Paik NJ, Kwon BS, Park YG.
    Arch Phys Med Rehabil; 2020 Sep 10; 101(9):1485-1496. PubMed ID: 32497599
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Botulinum toxin type A injection, followed by home-based functional training for upper limb hemiparesis after stroke.
    Takekawa T, Kakuda W, Taguchi K, Ishikawa A, Sase Y, Abo M.
    Int J Rehabil Res; 2012 Jun 10; 35(2):146-52. PubMed ID: 22453625
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU.
    J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    Curr Med Res Opin; 2010 Aug 15; 26(8):1983-92. PubMed ID: 20569068
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.